KR920701103A - 개선된 비닐에테르 제조방법 - Google Patents

개선된 비닐에테르 제조방법

Info

Publication number
KR920701103A
KR920701103A KR1019910700729A KR910700729A KR920701103A KR 920701103 A KR920701103 A KR 920701103A KR 1019910700729 A KR1019910700729 A KR 1019910700729A KR 910700729 A KR910700729 A KR 910700729A KR 920701103 A KR920701103 A KR 920701103A
Authority
KR
South Korea
Prior art keywords
group
titanium
metal
reducing agent
aryl
Prior art date
Application number
KR1019910700729A
Other languages
English (en)
Other versions
KR950001678B1 (ko
Inventor
아더 폴 스캅
Original Assignee
원본미기재
보오드 오브 거버너즈 오브 와이언 스테이트 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 보오드 오브 거버너즈 오브 와이언 스테이트 유니버시티 filed Critical 원본미기재
Publication of KR920701103A publication Critical patent/KR920701103A/ko
Application granted granted Critical
Publication of KR950001678B1 publication Critical patent/KR950001678B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/05—Preparation of ethers by addition of compounds to unsaturated compounds
    • C07C41/06—Preparation of ethers by addition of compounds to unsaturated compounds by addition of organic compounds only
    • C07C41/08—Preparation of ethers by addition of compounds to unsaturated compounds by addition of organic compounds only to carbon-to-carbon triple bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/15—Preparation of carboxylic acids or their salts, halides or anhydrides by reaction of organic compounds with carbon dioxide, e.g. Kolbe-Schmitt synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

개선된 비닐에테르 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (17)

  1. 유기용매속에서 다음 구조식(Ⅱ)으로 표현되는 카르보닐 함유 화합물을 역시 다음 구조식(Ⅲ)의 에스테르 화합물과 반응시켜서 아연금속, 티타늄염과 아민염기 존재하에 다음 구조식(Ⅰ)의 화합물을 제조하는 방법.
    여기서 A와 R은 수동적 유기그룹이고 ArOY는 히드록시기와 또한 P가 보호기일때 OP중에서 선택된 치환물인 OY로 치환된 아릴고리를 갖춘 아릴기이다.
  2. 제1항에 있어서, 금속형 환원제는 아연인 것을 특징으로 하는 방법.
  3. 제2항에 있어서, 티타늄은 3염화티타늄과 4염화티타늄 중에서 선택하는 것으로된 방법.
  4. 제3항에 있어서, 아민염기는 트리에릴아민이고 유기용매는 테트라히드로퓨란인 것으로된 방법.
  5. 제1항에 있어서, OY를 트리알킬실리옥시, 디알킬아릴 실리옥시, 디아릴알킬실리옥시와 트리아릴실리옥시 중에서 선택하여된 방법.
  6. 제1항에 있어서, OY가 히드록실기인 것으로된 방법.
  7. 유기용매속에서 다음구조식(Ⅴ)으로 표현되는 카르보닐 함유 화합물을 역시 다음 구조식(Ⅵ)의 에스테르 화합물과 반응시켜서 금속형 환원제, 티타늄금속염 또한 아민염기 존재하에 다음 구조식(Ⅳ)의 비닐에테르를 제조하는 방법에 대한 것이다.
    여기에 R1은 1내지 20 탄소원자를 함유한 알킬, 아릴 또한 아랄킬이고 때로는 산소, 황, 질소, 인 및 할로겐을 함유하며, R2는 아릴, 비아릴 및 치환 혹은 비치환된 융해고리 다중고리형 아릴기중에서 선택된 것이고 또한 R1과 R2는 탄소, 산소 및 질소함유기중에서 선택된 성분으로 함께 결합될 수 있고, R3C-는 6내지 30탄소원자를 함유한 다중고리형 알킬기중에서 선택하고, OY는 히드록시기와 또한 P가 보호기일때의 OP기중에서 선택된 치환물이다.
  8. 제7항에 있어서, 금속형 환원제는 아연인 것을 특징으로 하는 방법.
  9. 제8항에 있어서, 티타늄염은 3염화티타늄과 4염화티타늄중에서 선택하는 것으로된 방법.
  10. 제9항에 있어서, 아민염기는 트리에틸아민과 유기용매는 테트라히드로퓨란인 것으로된 방법.
  11. 제7항에 있어서, OY를 트리알킬실리옥시, 디알킬 아릴실리옥시, 디아릴알킬실리옥시와 트리아릴실리옥시중에서 선택하여된 방법.
  12. 제7항에 있어서, OY는 히드록실기인 것으로된 방법.
  13. 제7항에 있어서, 비닐에테르속의 Y가 OX기를 제공하는 또다른기로 대체되는 것을 특징으로 하는 방법.
  14. 제7항에 있어서, OX기를 무기 산소산염, 인산염, 산소-피라노시드, 아릴 및 알킬 카르복실 에스테르중에서 선택하여된 방법.
  15. 제1항에 있어서, 카르보닐 함유 화합물과 에스테르 화합물의 반응에 앞서서 금속형 환원제와 티타늄염 혼합물에 아민을 서서히 첨가하는 것으로된 방법.
  16. 제15항에 있어서, 티타늄염이 염화물인 것으로된 방법.
  17. 제16항에 있어서, 금속형 환원제는 미세하게 분쇄한 것인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910700729A 1989-12-14 1990-12-12 개선된 비닐에테르 제조방법 KR950001678B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/450,459 US4983779A (en) 1986-07-17 1989-12-14 Process for the preparation of vinyl ethers
PCT/US1990/007372 WO1991009002A1 (en) 1989-12-14 1990-12-12 Process for the preparation of vinyl ethers
US450459 1995-05-25
US450,459 1995-05-25

Publications (2)

Publication Number Publication Date
KR920701103A true KR920701103A (ko) 1992-08-11
KR950001678B1 KR950001678B1 (ko) 1995-02-28

Family

ID=23788187

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910700729A KR950001678B1 (ko) 1989-12-14 1990-12-12 개선된 비닐에테르 제조방법

Country Status (13)

Country Link
US (1) US4983779A (ko)
EP (1) EP0458965B1 (ko)
JP (2) JPH04505458A (ko)
KR (1) KR950001678B1 (ko)
CN (1) CN1020893C (ko)
AT (1) ATE128110T1 (ko)
AU (1) AU637194B2 (ko)
CA (1) CA2045553C (ko)
DE (1) DE69022582T2 (ko)
DK (1) DK0458965T3 (ko)
ES (1) ES2080296T3 (ko)
GR (1) GR3018174T3 (ko)
WO (1) WO1991009002A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0731201B2 (ja) 1987-12-31 1995-04-10 トロピックス・インコーポレーテッド 化学発光による測定法
US5582980A (en) * 1989-07-17 1996-12-10 Tropix, Inc. Chemiluminescent 1,2-dioxetanes
US6022964A (en) 1989-07-17 2000-02-08 Tropix, Inc. Chemiluminescent 1,2-dioxetanes
US5326882A (en) * 1989-07-17 1994-07-05 Tropix, Inc. Chemiluminescent 3-(substituted Adamant-2'-Ylidene) 1,2-dioxetanes
DE69130668T2 (de) * 1990-08-30 1999-05-20 Tropix Inc Chemolumineszente 3-(substituierte adamant-2'-ylidene)1,2-dioxetane
DE4210759A1 (de) * 1992-04-01 1993-10-07 Boehringer Mannheim Gmbh Substituierte Thiazolin-Dioxetan-Substrate, Verfahren zur Herstellung und Verwendung
EP0736174B1 (en) * 1993-12-23 2002-04-03 Tropix, Inc. Chemiluminescent energy transfer assays
US5773628A (en) * 1994-11-14 1998-06-30 Tropix, Inc. 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use
US5721370A (en) * 1995-07-31 1998-02-24 Lumigen Inc. Water soluble tri-substituted 1,2-dioxetane compounds and assay compositions having increased storage stability
US8796017B2 (en) 2003-05-21 2014-08-05 Jms Co., Ltd. Container for preparing serum and regenerative medical process using the same
CN100525906C (zh) * 2007-02-09 2009-08-12 上海华谊丙烯酸有限公司 缩醛气相分解催化剂及其制备方法
CN102030779A (zh) * 2010-11-17 2011-04-27 云南瑞亘生物科技有限公司 一种免疫分析用化学发光物amppd的制备方法
KR20180108697A (ko) * 2016-01-26 2018-10-04 라모트 앳 텔-아비브 유니버시티 리미티드 진단 및 인비보 영상용 화학발광 프로브
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
US9474768B1 (en) * 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857652A (en) * 1986-07-17 1989-08-15 Board Of Governors Of Wayne State University Chemiluminescent 1,2-dioxetane compounds

Also Published As

Publication number Publication date
KR950001678B1 (ko) 1995-02-28
JPH04505458A (ja) 1992-09-24
EP0458965A4 (en) 1993-07-28
ES2080296T3 (es) 1996-02-01
DE69022582D1 (de) 1995-10-26
DK0458965T3 (da) 1996-01-15
EP0458965B1 (en) 1995-09-20
ATE128110T1 (de) 1995-10-15
CN1020893C (zh) 1993-05-26
US4983779A (en) 1991-01-08
JPH03504815A (ja) 1991-10-24
CA2045553A1 (en) 1991-06-15
CA2045553C (en) 1999-04-13
WO1991009002A1 (en) 1991-06-27
CN1052478A (zh) 1991-06-26
AU7183391A (en) 1991-07-18
EP0458965A1 (en) 1991-12-04
GR3018174T3 (en) 1996-02-29
JPH0825941B2 (ja) 1996-03-13
DE69022582T2 (de) 1996-03-07
AU637194B2 (en) 1993-05-20

Similar Documents

Publication Publication Date Title
KR920701103A (ko) 개선된 비닐에테르 제조방법
SE7909655L (sv) Sett att framstella treo-3-amino-2-hydroxibutyrylaminoettiksyror samt even nya mellanprodukter derfor och sett att framstella dessa
US3809699A (en) Process for producing 6-amino-penicillanic acid
KR950701902A (ko) 리그난계 화합물의 제조방법(process for producing lignan compound)
KR920006358A (ko) 1-메틸카르바펜엠 유도체 및 그의 제조방법
KR830005257A (ko) 알도헥소즈 유도체의 제조방법
DE2708219A1 (de) Verfahren zur herstellung von 7-oxocephalosporansaeure- und 6-oxopenicillansaeure-verbindungen
KR850005414A (ko) 치환된 5,11-디하이드로-6H-디벤즈 [b.e]아제핀-6-온의 제조방법
DE3382761D1 (de) Verfahren zur Herstellung von Penem-Verbindungen.
KR840004430A (ko) 카르바페넴유도체의 제조 방법
KR850007601A (ko) 페남 유도체의 제조방법
KR950013578B1 (ko) 신규 티아(디아)졸 초산의 반응성 티오포스페이트 유도체 및 그의 제조방법
KR830001941A (ko) β-락타마제-억제제로서의 6-B-치환 페닐실란산의 제조방법
KR850005847A (ko) 피리미도[2,1-b] 벤조티아졸 및 그것의 염들의 제조방법
GB9224702D0 (en) Boronic ester synthesis
KR870003107A (ko) 키산틴 유도체의 제조방법
EP0391415A3 (en) Naphthalocyanine compounds and production thereof
KR870011080A (ko) 4-할로게노-2-옥시이미노-3-옥소부티르산류의 제조방법
KR910007919A (ko) 3'-아지도-3'-데옥시티미딘의 합성공정
KR880005138A (ko) 신규 화합물들
HUT40995A (en) Process for producing esters of 4-/acyloxy/-3-oxo-butiric acid
AU666559B2 (en) 4-acylthio azetidinones
KR850001742A (ko) 큐말산 에스테르의 제조방법
ES8302687A1 (es) "procedimiento para la preparacion de derivados de 2-oxa-biciclo (3.3.0) octano".
DE2615621A1 (de) Beta-lactam-antibiotika und -zwischenprodukte sowie ihr herstellungsverfahren

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090226

Year of fee payment: 15

LAPS Lapse due to unpaid annual fee